Clinical Trial Update: Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing a response-adapted strategy in follicular non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Non-hodgkin Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Follicular Non-Hodgkin's Lymphoma | Phase 3 | Status: COMPLETED